Our results demonstrated that TROP2 expression was significantly increased in vivo in airway BCs of COPD patients, and revealed a significant correlation between TROP2 expression and the degree of airway epithelium hyperplasia. Here, TACSTD2 is linked to chronic obstructive pulmonary disease.